A detailed history of Bvf Inc transactions in Galapagos Nv stock. As of the latest transaction made, Bvf Inc holds 1,569,422 shares of GLPG stock, worth $40.2 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares
1,569,422
Previous 1,569,422 -0.0%
Holding current value
$40.2 Million
Previous $38.9 Million 16.18%
% of portfolio
1.44%
Previous 1.19%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$24.78 - $32.48 $7.29 Million - $9.56 Million
-294,387 Reduced 15.79%
1,569,422 $38.9 Million
Q1 2024

May 15, 2024

SELL
$32.2 - $42.44 $1.65 Million - $2.18 Million
-51,300 Reduced 2.68%
1,863,809 $60 Million
Q3 2023

Nov 14, 2023

SELL
$34.17 - $42.98 $8.54 Million - $10.7 Million
-250,000 Reduced 11.55%
1,915,109 $66.2 Million
Q1 2023

May 15, 2023

BUY
$36.5 - $48.0 $75.4 Million - $99.1 Million
2,065,109 Added 2065.11%
2,165,109 $83.7 Million
Q4 2022

Feb 14, 2023

BUY
$37.44 - $46.51 $3.74 Million - $4.65 Million
100,000 New
100,000 $4.44 Million
Q2 2022

Aug 15, 2022

SELL
$52.3 - $71.59 $54.7 Million - $74.9 Million
-1,046,283 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$51.32 - $68.5 $5.65 Million - $7.54 Million
-110,110 Reduced 9.52%
1,046,283 $64.9 Million
Q4 2021

Feb 14, 2022

BUY
$47.03 - $57.12 $1.72 Million - $2.09 Million
36,660 Added 3.27%
1,156,393 $63.8 Million
Q3 2021

Nov 15, 2021

BUY
$52.17 - $70.2 $58.4 Million - $78.6 Million
1,119,733 New
1,119,733 $58.9 Million
Q2 2020

Aug 14, 2020

SELL
$185.52 - $231.25 $1.42 Million - $1.77 Million
-7,674 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$143.0 - $274.03 $1.1 Million - $2.1 Million
7,674 New
7,674 $1.5 Million
Q4 2019

Feb 14, 2020

SELL
$146.12 - $215.82 $44.6 Million - $65.8 Million
-305,076 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$130.44 - $187.64 $39.8 Million - $57.2 Million
305,076 New
305,076 $46.6 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.69B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.